Hadjigapor, Aljavar C.
HRN: 16-18-01 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/25/2025
CEFUROXIME 750MG (VIAL)
07/25/2025
08/01/2025
IV
750mg
Q8H
URTI
Checking Initial Appropriateness
07/27/2025
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
07/27/2025
08/06/2025
PO
12 Ml
Q 8 Hours
Intestinal Amoebiasis
Checking Initial Appropriateness
07/30/2025
NYSTATIN 100,000IU/ML, 30ML SUSPENSION (BOT)
07/30/2025
08/06/2025
ORAL
4ml
QID
Oral Thrush
Checking Initial Appropriateness
07/30/2025
CEFTRIAXONE 1G (VIAL)
07/29/2025
08/05/2025
IV
2g
OD
URTI
Checking Initial Appropriateness